Mariana P C Ribeiro
Overview
Explore the profile of Mariana P C Ribeiro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
179
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Jimenez J, Bru S, Ribeiro M, Clotet J
Curr Genet
. 2016 May;
63(1):15-18.
PMID: 27221322
Phosphate is one of the essential elements supporting life. Cells accumulate phosphate in the form of a molecule called polyphosphate (polyP), which carries many functions in the physiology of cells...
12.
Ribeiro M, Santos A, Custodio J
Eur J Pharmacol
. 2015 Jul;
764:372-378.
PMID: 26165763
The use of the antiestrogen tamoxifen in melanoma therapy is controversial due to the unsuccessful outcomes and a still rather unclarified mechanism of action. It seemed that the days of...
13.
Ribeiro M, Santos A, Custodio J
Cancer Lett
. 2014 Jul;
353(1):17-24.
PMID: 25042865
All-trans-retinoic acid (RA) is a promising agent for breast cancer treatment, but it induces several adverse effects and the few clinical trials performed up to now in breast cancer patients...
14.
Ribeiro M, Santos A, Custodio J
Toxicology
. 2014 Jun;
323:10-8.
PMID: 24881593
Tamoxifen (TAM) is routinely used in the treatment of breast carcinoma. TAM-induced liver injury remains a major concern, as TAM causes hepatic steatosis in a significant number of patients, which...
15.
Ribeiro M, Nunes-Correia I, Santos A, Custodio J
Exp Cell Res
. 2013 Nov;
321(2):288-96.
PMID: 24240127
Recent reports suggest that N-methyl-d-aspartate receptor (NMDAR) blockade by MK-801 decreases tumor growth. Thus, we investigated whether other ionotropic glutamate receptor (iGluR) antagonists were also able to modulate the proliferation...
16.
Silva F, Ribeiro M, Santos M, Rocha-Pereira P, Santos-Silva A, Custodio J
J Bioenerg Biomembr
. 2013 Jun;
45(4):383-96.
PMID: 23779226
The combination of isotretinoin (13-cis-retinoic acid) with antiestrogens seems to be a promising strategy for cancer chemotherapy. The aim of the study was to evaluate the effects of isotretinoin alone...
17.
Ribeiro M, Santos A, Santos M, Custodio J
Life Sci
. 2013 Jun;
93(2-3):96-107.
PMID: 23764110
Aims: The clinical utilization of the combinations of all-trans-retinoic acid (RA) with antiestrogens, which present synergism of action in breast cancer, has been limited by RA adverse effects, including hepatotoxicity,...
18.
Ribeiro M, Silva F, Paixao J, Santos A, Custodio J
Eur J Pharmacol
. 2013 May;
715(1-3):354-62.
PMID: 23712006
Melanoma incidence is dramatically increasing and the available treatments beyond partial efficacy have severe side effects. Retinoids are promising anticancer agents, but their clinical use has been limited by their...
19.
Silva F, Ribeiro M, Santos M, Rocha-Pereira P, Santos-Silva A, Custodio J
Toxicology
. 2013 Feb;
306:93-100.
PMID: 23384448
Acitretin is a synthetic retinoid used for severe extensive psoriasis and it has been shown to be an effective and a safe therapeutic drug for other diseases including cancer when...
20.
Ribeiro M, Silva F, Santos A, Santos M, Custodio J
Toxicol Appl Pharmacol
. 2013 Jan;
267(1):104-12.
PMID: 23274567
Endoxifen (EDX) is a key active metabolite of tamoxifen (TAM) with higher affinity and specificity to estrogen receptors that also inhibits aromatase activity. It is safe and well tolerated by...